Results 11 to 20 of about 93,278,916 (238)

Developing Galectin-3-Targeted Therapeutics in Diseases: Three Distinct Galectin-3 Segments for Targeting [PDF]

open access: yesExpert Reviews in Molecular Medicine
The β-galactoside-binding protein galectin-3 is currently a hotly pursued therapeutic target in cancer, inflammation and fibrosis-associated diseases due to its multi-mode actions and broad impact on the pathogenesis and progress of the diseases. Various
Paulina Sindrewicz-Goral   +3 more
doaj   +2 more sources

The role of galectin-3 and galectin-9 in the chronic inflammation of rheumatoid arthritis [PDF]

open access: yes, 2009
Fibroblasts are important regulators of inflammatory processes. The phenotype of fibroblasts differ according to anatomical site which may dtermine immune functions such as leukocyte accumulation and predilection for inflammatory disease in certain ...
Bik, Magadelena Anna
core   +7 more sources

Galectin-3 and the skin [PDF]

open access: yesJournal of Dermatological Science, 2011
Galectin-3 is highly expressed in epithelial cells including keratinocytes and is involved in the pathogenesis of inflammatory skin diseases by affecting the functions of immune cells. For example, galectin-3 can contribute to atopic dermatitis (AD) by promoting polarization toward a Th2 immune response by regulating dendritic cell (DC) and T cell ...
Larissa, Larsen   +3 more
openaire   +2 more sources

Galectin-3 in Cardiovascular Diseases

open access: yesInternational Journal of Molecular Sciences, 2020
Galectin-3 (Gal-3) is a β-galactoside-binding protein belonging to the lectin family with pleiotropic regulatory activities and several physiological cellular functions, such as cellular growth, proliferation, apoptosis, differentiation, cellular adhesion, and tissue repair. Inflammation, tissue fibrosis and angiogenesis are the main processes in which
Blanda Valeria   +3 more
openaire   +3 more sources

Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. [PDF]

open access: yes, 2012
The S-type lectin galectin-9 binds to the negative regulatory molecule Tim-3 on T cells and induces their apoptotic deletion or functional inactivation.
Cheng, Y   +59 more
core   +1 more source

Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer [PDF]

open access: yes, 2005
Objective: To determine the expression of endogenous adhesion/growth-regulatory lectins and their binding sites using labeled tissue lectins as well as the binding profile of hyaluronic acid as an approach to define new prognostic markers.
Szöke, Tamas   +9 more
core   +1 more source

The role of galectin-3 and galectin-3–binding protein in venous thrombosis [PDF]

open access: yesBlood, 2015
Key PointsWe determined the location of gal3bp and gal3 and their role in promoting VT and leukocyte/endothelial cell interactions for the first time. Gal3bp and gal3 have the potential to be used as targets for future VT therapies.
Elise P, DeRoo   +8 more
openaire   +2 more sources

Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. [PDF]

open access: yes, 2015
Inflammatory response induced by microglia plays a critical role in the demise of neuronal populations in neuroinflammatory diseases. Although the role of toll-like receptor 4 (TLR4) in microglia's inflammatory response is fully acknowledged, little is ...
Martina Svensson   +83 more
core   +1 more source

The Role of Galectin-3 in the Kidneys [PDF]

open access: yesInternational Journal of Molecular Sciences, 2016
Galectin-3 is a 32- to 35-kDa member of the galectin family of b-galactoside-binding lectins, which is characterized by a carbohydrate recognition domain. Through its carbohydrate-binding function, it regulates cell growth, differentiation, and inflammation. It also plays a complex, context-dependent role in the kidneys. During development, it promotes
Szu-Chia Chen, Po-Lin Kuo
openaire   +2 more sources

Intensity and Grading of Galectin-3 Expression as a Sole Marker to Differentiate Benign and Malignant Thyroid Neoplasms

open access: yesNational Journal of Laboratory Medicine, 2019
Introduction: Errors in categorization of thyroid neoplasms as benign or malignant has management implications. In several studies Galectin-3 was one of the most reliable markers for malignancy in thyroid.
Pallavi Vijay Borkar   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy